1 January 2024 false Taxfiler 2024.6 12265125business:PrivateLimitedCompanyLtd2024-01-012024-12-31 122651252023-12-31 122651252024-01-012024-12-31 12265125business:AuditExemptWithAccountantsReport2024-01-012024-12-31 12265125business:FilletedAccounts2024-01-012024-12-31 122651252024-12-31 12265125business:Director12024-01-012024-12-31 12265125business:Director22024-01-012024-12-31 12265125business:Director32024-01-012024-12-31 12265125business:RegisteredOffice2024-01-012024-12-31 122651252023-12-31 12265125core:WithinOneYear2024-12-31 12265125core:WithinOneYear2023-12-31 12265125core:AfterOneYear2024-12-31 12265125core:AfterOneYear2023-12-31 12265125core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 12265125core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 12265125core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 12265125core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 12265125core:PreviouslyStatedAmount2024-12-31 12265125core:PreviouslyStatedAmount2023-12-31 12265125business:SmallEntities2024-01-012024-12-31 12265125countries:EnglandWales2024-01-012024-12-31 12265125core:MotorVehicles2024-01-012024-12-31 12265125core:FurnitureFittings2024-01-012024-12-31 12265125core:Goodwill2023-12-31 12265125core:Goodwill2024-12-31 12265125core:Goodwill2024-01-012024-12-31 12265125core:MotorVehicles2023-12-31 12265125core:FurnitureFittings2023-12-31 12265125core:MotorVehicles2024-12-31 12265125core:FurnitureFittings2024-12-31 12265125business:OrdinaryShareClass12024-01-012024-12-31 12265125business:OrdinaryShareClass12023-01-012023-12-31 122651252023-01-012023-12-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 12265125 (England and Wales)
Woodend Pharma Ltd Filleted accounts for the year ended 31 December 2024
Woodend Pharma Ltd Filleted accounts Contents
Page
- 2 -
Woodend Pharma Ltd Company Information for the year ended 31 December 2024
Directors
Gulam Jaffer Nabi Jasjeev Singh Rai Danish Ahmed Vitran
Company Number
12265125 (England and Wales)
Registered Office
104 Hinckley Road Coventry CV2 2EU
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Woodend Pharma Ltd Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
639,897 
701,516 
Tangible assets
- 
4,000 
639,897 
705,516 
Current assets
Inventories
50,000 
25,000 
Debtors
416,090 
430,775 
Cash at bank and in hand
122,864 
(258,367)
588,954 
197,408 
Creditors: amounts falling due within one year
(399,392)
(475,139)
Net current assets/(liabilities)
189,562 
(277,731)
Total assets less current liabilities
829,459 
427,785 
Creditors: amounts falling due after more than one year
(769,304)
(388,996)
Net assets
60,155 
38,789 
Capital and reserves
Called up share capital
3 
3 
Profit and loss account
60,152 
38,786 
Shareholders' funds
60,155 
38,789 
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 3 December 2025 and were signed on its behalf by
Gulam Jaffer Nabi Director Company Registration No. 12265125
- 4 -
Woodend Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
Woodend Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12265125. The registered office is 104 Hinckley Road, Coventry, CV2 2EU.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Motor vehicles
25% straight line
Fixtures & fittings
20% straight line
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Inventories
Inventories have been valued at the lower of cost and estimated selling price less costs to complete and sell. In respect of work in progress and finished goods, cost includes a relevant proportion of overheads according to the stage of manufacturing/completion.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 5 -
Woodend Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
Pension costs
The company operates a defined contribution scheme for the benefit of its employees. Contributions payable are recognised in the profit and loss account when due.
4
Intangible fixed assets
Goodwill 
£ 
Cost
At 1 January 2024
947,992 
At 31 December 2024
947,992 
Amortisation
At 1 January 2024
246,476 
Charge for the year
61,619 
At 31 December 2024
308,095 
Net book value
At 31 December 2024
639,897 
At 31 December 2023
701,516 
5
Tangible fixed assets
Motor vehicles 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 January 2024
7,000 
20,000 
27,000 
At 31 December 2024
7,000 
20,000 
27,000 
Depreciation
At 1 January 2024
7,000 
16,000 
23,000 
Charge for the year
- 
4,000 
4,000 
At 31 December 2024
7,000 
20,000 
27,000 
Net book value
At 31 December 2024
- 
- 
- 
At 31 December 2023
- 
4,000 
4,000 
6
Inventories
2024 
2023 
£ 
£ 
Finished goods
50,000 
25,000 
50,000 
25,000 
- 6 -
Woodend Pharma Ltd Notes to the Accounts for the year ended 31 December 2024
7
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
VAT
15,458 
26,278 
Trade debtors
97,781 
101,646 
113,239 
127,924 
Amounts falling due after more than one year
Amounts due from group undertakings etc.
302,851 
302,851 
8
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Bank loans and overdrafts
62,951 
230,294 
Trade creditors
131,711 
159,524 
Taxes and social security
54,648 
44,843 
Other creditors
147,110 
38,992 
Accruals
2,972 
1,486 
399,392 
475,139 
9
Creditors: amounts falling due after more than one year
2024 
2023 
£ 
£ 
Bank loans
504,256 
40,278 
Loans from directors
265,048 
348,718 
769,304 
388,996 
10
Share capital
2024 
2023 
£ 
£ 
Allotted, called up and fully paid:
3 Ordinary shares of £1 each
3 
3 
11
Average number of employees
During the year the average number of employees was 10 (2023: 8).
- 7 -